Nitric oxide: novel therapy for osteoporosis
- 12 November 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 9 (17) , 3025-3044
Abstract
Background: Relative nitric oxide (NO) deficiency is responsible for many pathophysiological processes, including in postmenopausal women providing a plausible biological basis for use of NO replac...Keywords
This publication has 89 references indexed in Scilit:
- Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-αExperimental Cell Research, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Nitroglycerin Therapy Is as Efficacious as Standard Estrogen Replacement Therapy (Premarin) in Prevention of Oophorectomy-Induced Bone Loss: A Human Pilot Clinical StudyJournal of Bone and Mineral Research, 2000
- Nitric Oxide Mediates 17β-Estradiol-Stimulated Human and Rodent Osteoblast Proliferation and DifferentiationBiochemical and Biophysical Research Communications, 2000
- Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studiesAmerican Heart Journal, 1999
- Estrogen Increases Endothelial Nitric Oxide by a Receptor Mediated SystemBiochemical and Biophysical Research Communications, 1995
- Arginine supplementation in the prevention and treatment of osteoporosisMedical Hypotheses, 1994
- Circulating Nitrite/Nitrate Levels Increase with Follicular Development: Indirect Evidence for Estradiol-Mediated NO ReleaseBiochemical and Biophysical Research Communications, 1994
- Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitroBiochemical and Biophysical Research Communications, 1992
- Endothelium-derived relaxing factorPharmacology & Therapeutics, 1989